27/04/2020 Axsome Therapeutics announces top-line results for its ADVANCE-1 Phase II/III trial in AD agitation Science watch
27/04/2020 Shanghai Green Valley Pharmaceuticals gets approval from FDA for Phase III study of Oligomannate in mild to moderate Alzheimer's disease Science watch
22/04/2020 Clinical study published in Lancet Neurology validates a plasma p-Tau181 assay as a diagnostic test for Alzheimer’s disease Science watch
22/04/2020 A new study reports an association between long-term flavonoid-rich foods and a reduced risk of Alzheimer’s disease and related dementias Science watch
21/04/2020 Sean Mackell, a member of the Irish Dementia Working Group, shares his experiences of the COVID-19 situation Living with dementia
21/04/2020 PARADIGM holds two-day virtual meeting to discuss its Patient Engagement toolbox EU projects
20/04/2020 Panhellenic Federation of Alzheimer’s Disease and Related Disorders take part in Erasmus+ project “iCONNECT” Members' news
